Sequence information
Variant position: 349 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 592 The length of the canonical sequence.
Location on the sequence:
QKAIAHYEQQMGQKVQLPTE
T LQELLDLHRDSEREAIEVFI
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human QKAIAHYEQQMGQKVQLPTET LQELLDLHRDSEREAIEVFI
Mouse QKAITYYEEQMNQKIHMPTET LQELLDLHRTCEREAIEVFM
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 589
Guanylate-binding protein 1
Literature citations
Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP.
Cheng Y.-S.E.; Patterson C.E.; Staeheli P.;
Mol. Cell. Biol. 11:4717-4725(1991)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS SER-349 AND GLY-409;
Cloning of human full-length CDSs in BD Creator(TM) system donor vector.
Kalnine N.; Chen X.; Rolfs A.; Halleck A.; Hines L.; Eisenstein S.; Koundinya M.; Raphael J.; Moreira D.; Kelley T.; LaBaer J.; Lin Y.; Phelan M.; Farmer A.;
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANTS SER-349 AND GLY-409;
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANTS SER-349 AND GLY-409;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.